The patient's sister, a 14-year-old, presented with short episodes of choreo-dystonic movements of the left arm and neck that appeared when she started to run since the age of 10. These episodes usually last a few seconds and occur at least 10 times per day. Her consciousness level was normal during episodes. Her medical history included migraine. She was diagnosed as having paroxysmal kinesigenic dyskinesias (PKD). Treatment with carbamazepine led to a complete remission of the movements.
There was no family history of epilepsy or infantile convulsions. The patient's mother had severe recurrent migraine headaches. Her maternal cousin had been diagnosed with PKD.
The patient, her 2 sisters (1 healthy and the other affected with PKD), and their mother were available for PRRT2 mutation screen (figure 2). Direct sequencing identified a heterozygous truncating mutation in the proband, her mother, and the symptomatic sister: GRC37/hg19: chr16:29825025 GA/A, NM_145239: c.650delG, producing the amino acid change NP_660282.2: p.R217Qfs*12. This variant is not listed in public genomic databases, including ExAC (exac.broadinstitute.org/).
Discussion
Herein, we describe a patient with "galloping tongue" syndrome who was positive for the p.R217Q fs*12 mutation in the PRRT2 gene. Galloping tongue is an uncommon movement disorder. [1] [2] [3] [4] [5] The characteristics of these lingual movements have been variably described as transverse contractions, twisting, or undulating movements. [2] [3] [4] [5] Although these movements were present with the tongue at rest in most of the reported patients, in some cases the movements were also observed during sustained action.
Our patient had a mutation in the PRRT2 gene known to be associated with PKD. 6 However, she did not have the typical paroxysmal dyskinesias seen in PKD. Her abnormal movements were triggered by action but were not paroxysmal because they were present as long as the voluntary movement motion persisted, resembling an action dystonia. The topography of dyskinesia, isolated to the tongue, was also uncharacteristic of PKD. Still, we believe that the PRRT2 mutation could be linked to the patient's movement disorder because it is action related and known causes of the disorder have been ruled out. Furthermore, the phenotype of PRRT2 mutations is not limited to dystonia and chorea typical of PKD, but episodic ataxia and paroxysmal torticollis have also been described. 7 Seizures and migraine seem to be also part of the clinical spectrum. 6 The cause of the lingual movements in our patient remains uncertain. A functional movement disorder seemed unlikely because the movement disorder could not be disrupted, suppressed, or entrained with examiner maneuvers, which had no impact in the patient's life, and there was no obvious gain for the patient. The study of similar cases and additional PRRT2 families will eventually clarify whether the "galloping tongue" syndrome is indeed a previously unrecognized manifestation of PRRT2 mutations. 
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